换一批
换一批
作者：
Nonhlanhla N,Mkhize [1]
;
Anna E J,Yssel [2]
;
Haajira,Kaldine [1]
;
Rebecca T,van Dorsten [3]
;
Amanda S,Woodward Davis [4]
;
Nicolas,Beaume [2]
;
David,Matten [2]
;
Bronwen,Lambson [1]
;
Tandile,Modise [1]
;
Prudence,Kgagudi [1]
;
Talita,York [2]
;
Dylan H,Westfall [5]
;
Elena E,Giorgi [4]
;
Bette,Korber [6]
;
Colin,Anthony [2]
;
Rutendo E,Mapengo [1]
;
Valerie,Bekker [7]
;
Elizabeth,Domin [8]
;
Amanda,Eaton [8]
;
Wenjie,Deng [5]
;
Allan,DeCamp [4]
;
Yunda,Huang [4]
;
Peter B,Gilbert [4]
;
Asanda,Gwashu-Nyangiwe [2]
;
Ruwayhida,Thebus [2]
;
Nonkululeko,Ndabambi [2]
;
Dieter,Mielke [9]
;
Nyaradzo,Mgodi [10]
;
Shelly,Karuna [4]
;
Srilatha,Edupuganti [11]
;
Michael S,Seaman [12]
;
Lawrence,Corey [13]
;
Myron S,Cohen [14]
;
John,Hural [4]
;
M Juliana,McElrath [4]
;
James I,Mullins [5]
;
David,Montefiori [8]
;
Penny L,Moore [15]
;
Carolyn,Williamson [16]
;
Lynn,Morris [15]
作者单位：
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.;SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
[1]
Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
[2]
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.;SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.;South African Medical Research Council Antiviral Gene Therapy Research Unit, School of Pathology, Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa.
[3]
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
[4]
Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
[5]
Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
[6]
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
[7]
Department of Surgery, Duke University, Durham, North Carolina, United States of America.
[8]
Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.;Department of Surgery, Duke University, Durham, North Carolina, United States of America.
[9]
University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
[10]
Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, United States of America.
[11]
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
[12]
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.;Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.
[13]
Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North-Carolina, United States of America.
[14]
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.;SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.;Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
[15]
Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.;Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.;National Health Laboratory Service, Cape Town, South Africa.
[16]
主题词
人类(Humans);HIV感染(HIV Infections);HIV抗体(HIV Antibodies);抗体, 中和(Antibodies, Neutralizing);HIV-1(HIV-1);HIV血清阳性(HIV Seropositivity);多糖类(Polysaccharides)
DOI
10.1371/journal.ppat.1011469
PMID
37384759
发布时间
2024-09-21
- 浏览0
PLoS pathogens
PLoS pathogens
e1011469页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
